Dem bill would undo big lobbying win for drug maker Amgen

ADVERTISEMENT
"Without scrutiny or debate, the American taxpayer was stuck with the $500 million tab," Welch said in a statement. "This special interest provision should have stood on its own merits with an up or down vote. It’s no wonder cockroaches and root canals are more popular than Congress.”


More in Healthcare

Obama unveils $1.2B plan to tackle drug-resistant bacteria

Read more »